The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes

被引:337
作者
Monnier, Louis [1 ]
Dunseath, Gareth J.
Colette, Claude
Owens, David R.
机构
[1] Lapeyronie Hosp, Dept Metab Dis, F-34295 Montpellier 5, France
[2] Univ Montpellier, Inst Clin Res, Lab Human Nutr & Atherogenesis, F-34059 Montpellier, France
[3] Llandough Hosp, Acad Ctr, Diabet Res Unit, Cardiff, Wales
关键词
D O I
10.2337/dc06-1612
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-The aim of the study was to determine whether the loss of fasting and postprandial glycemic control occurs in parallel or sequentially in the evolution of type 2 diabetes. RESEARCH DESIGN AND METHODS-in 130 type 2 diabetic patients, 24-h glucose profiles were obtained using a continuous glucose monitoring system. The individuals with type 2 diabetes were divided into five groups according to A1C levels: 1 (< 6.5%, n = 30), 2 (6.5-6.9%, It = 17), 3 (7-7.9%, n = 32),4 (8-8.9%, n = 25), and 5 (>= 9%, It = 26). The glucose profiles between the groups were compared. The overall glucose concentrations for the diurnal, nocturnal, and morning periods, which represent the postprandial, fasting, and the dawn phenomenon states, respectively, were also compared. RESULTS-Glucose concentrations increased steadily from group 1 to 5 in a stepwise manner. The initial differences in mean glucose concentrations reaching statistical significance occurred 1) between groups 1 and 2 (6.4 vs. 7.7 mmol/l, P = 0.0004) for daytime postprandial periods, followed by differences; 2) between groups 2 and 3 (7.5 vs. 9.3 mmol/l, P = 0.0003) for the morning periods (dawn phenomenon); and finally 3) between groups 3 and 4 (6.3 vs. 8.4 mmol/l, P < 0.0001) for nocturnal fasting periods. CONCLUSIONS-The deterioration of glucose homeostasis in individuals with type 2 diabetes progressed from postprandial to fasting hyperglycemia following a three-Step process. The first step related to the three diurnal postmeal periods considered as a whole, the second step occurred during the morning period, and the third and final step corresponded to sustained hyperglycemia over the nocturnal fasting periods. Such a description of evolution of type 2 diabetes may be of interest for implementing antidiabetes treatment.
引用
收藏
页码:263 / 269
页数:7
相关论文
共 30 条
[21]   Evaluation of the analytic performances of the new HPLC system HLC-723 G7 for the measurement of hemoglobin A1C [J].
Terreni, A ;
Paleari, R ;
Caldini, A ;
Ognibene, A ;
Mosca, A ;
Messeri, G .
CLINICAL BIOCHEMISTRY, 2003, 36 (08) :607-610
[22]   Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. [J].
Tuomilehto, J ;
Lindström, J ;
Eriksson, JG ;
Valle, TT ;
Hamalainen, H ;
Ilanne-Parikka, P ;
Keinanen-Kiukaanniemi, S ;
Laakso, M ;
Louheranta, A ;
Rastas, M ;
Salminen, V ;
Uusitupa, M ;
Aunola, S ;
Cepaitis, Z ;
Moltchanov, V ;
Hakumaki, M ;
Mannelin, M ;
Martikkala, V ;
Sundvall, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (18) :1343-1350
[23]   Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].
Turner, RC ;
Holman, RR ;
Cull, CA ;
Stratton, IM ;
Matthews, DR ;
Frighi, V ;
Manley, SE ;
Neil, A ;
McElroy, K ;
Wright, D ;
Kohner, E ;
Fox, C ;
Hadden, D ;
Mehta, Z ;
Smith, A ;
Nugent, Z ;
Peto, R ;
Adlel, AI ;
Mann, JI ;
Bassett, PA ;
Oakes, SF ;
Dornan, TL ;
Aldington, S ;
Lipinski, H ;
Collum, R ;
Harrison, K ;
MacIntyre, C ;
Skinner, S ;
Mortemore, A ;
Nelson, D ;
Cockley, S ;
Levien, S ;
Bodsworth, L ;
Willox, R ;
Biggs, T ;
Dove, S ;
Beattie, E ;
Gradwell, M ;
Staples, S ;
Lam, R ;
Taylor, F ;
Leung, L ;
Carter, RD ;
Brownlee, SM ;
Fisher, KE ;
Islam, K ;
Jelfs, R ;
Williams, PA ;
Williams, FA ;
Sutton, PJ .
LANCET, 1998, 352 (9131) :837-853
[24]   Incretins, insulin secretion and Type 2 diabetes mellitus [J].
Vilsboll, T ;
Holst, JJ .
DIABETOLOGIA, 2004, 47 (03) :357-366
[25]   The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus [J].
Weyer, C ;
Bogardus, C ;
Mott, DM ;
Pratley, RE .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (06) :787-794
[26]  
Woerle HJ, 2005, DIABETES, V54, pA76
[27]   Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin A1c values [J].
Woerle, HJ ;
Pimenta, WP ;
Meyer, C ;
Gosmanov, NR ;
Szoke, E ;
Szombathy, T ;
Mitrakou, A ;
Gerich, JE .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (15) :1627-1632
[28]  
Wolever T M, 1990, World Rev Nutr Diet, V62, P120
[29]   Insulin glargine or NPH combined with metformin in type 2 diabetes:: the LANMET study [J].
Yki-Järvinen, H ;
Kauppinen-Mäkelin, R ;
Tiikkainen, M ;
Vähätalo, M ;
Virtamo, H ;
Nikkilä, K ;
Tulokas, T ;
Hulme, S ;
Hardy, K ;
McNulty, S ;
Hänninen, J ;
Levänen, H ;
Lahdenperä, S ;
Lehtonen, R ;
Ryysy, L .
DIABETOLOGIA, 2006, 49 (03) :442-451
[30]  
ZAR JH, 1999, BIOSTAT ANAL, P461